Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice.

José Luis Revuelta-HerreroA Giménez-ManzorroA Matilla-PeñaA Herranz-AlonsoM Sanjurjo-Sáez

Published in: Journal of clinical pharmacy and therapeutics (2018)

The concurrent use of OBV/PTV/r+DSV with sorafenib was considered safe and effective.

Keyphrases